Literature DB >> 26104008

FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation.

Abdulrzag F Ahmed1,2, Charles E de Bock1,2,3, Lisa F Lincz1,2,4, Jay Pundavela1,2, Ihssane Zouikr1,2, Estelle Sontag1,5, Hubert Hondermarck1,2, Rick F Thorne6,7.   

Abstract

The Hippo pathway is emerging as a critical nexus that balances self-renewal of progenitors against differentiation; however, upstream elements in vertebrate Hippo signalling are poorly understood. High expression of Fat1 cadherin within the developing neuroepithelium and the manifestation of severe neurological phenotypes in Fat1-knockout mice suggest roles in neurogenesis. Using the SH-SY5Y model of neuronal differentiation and employing gene silencing techniques, we show that FAT1 acts to control neurite outgrowth, also driving cells towards terminal differentiation via inhibitory effects on proliferation. FAT1 actions were shown to be mediated through Hippo signalling where it activated core Hippo kinase components and antagonised functions of the Hippo effector TAZ. Suppression of FAT1 promoted the nucleocytoplasmic shuttling of TAZ leading to enhanced transcription of the Hippo target gene CTGF together with accompanying increases in nuclear levels of Smad3. Silencing of TAZ reversed the effects of FAT1 depletion thus connecting inactivation of TAZ-TGFbeta signalling with Hippo signalling mediated through FAT1. These findings establish FAT1 as a new upstream Hippo element regulating early stages of differentiation in neuronal cells.

Entities:  

Keywords:  Cadherin; Differentiation; FAT1 cadherin; Hippo pathway; Neurite outgrowth; Neuronal differentiation; SMAD transcription factor; TAZ; TGFβ signalling

Mesh:

Substances:

Year:  2015        PMID: 26104008     DOI: 10.1007/s00018-015-1955-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  76 in total

Review 1.  The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation.

Authors:  Huan Liu; Dandan Jiang; Fangtao Chi; Bin Zhao
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

2.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

Review 3.  The cell biology of neurogenesis.

Authors:  Magdalena Götz; Wieland B Huttner
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

4.  A new kid on the TGFbeta block: TAZ controls Smad nucleocytoplasmic shuttling.

Authors:  Katharine H Wrighton; Fangyan Dai; Xin-Hua Feng
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

5.  Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation.

Authors:  Amar M Singh; David Reynolds; Timothy Cliff; Satoshi Ohtsuka; Alexa L Mattheyses; Yuhua Sun; Laura Menendez; Michael Kulik; Stephen Dalton
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

6.  TPA-induced neurite formation in a neuroblastoma cell line (SH-SY5Y) is associated with increased IGF-I receptor mRNA and binding.

Authors:  A Ota; Z Shen-Orr; C T Roberts; D LeRoith
Journal:  Brain Res Mol Brain Res       Date:  1989-07

7.  The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway.

Authors:  Elizabeth Silva; Yonit Tsatskis; Laura Gardano; Nic Tapon; Helen McNeill
Journal:  Curr Biol       Date:  2006-09-21       Impact factor: 10.834

8.  DHEA provides a microenvironment for endometrial stem cells neurogenesis.

Authors:  Alireza Shoae-Hassani; Seyed Abdolreza Mortazavi-Tabatabaei; Shiva Sharif; Hamidreza Rezaei-Khaligh; Javad Verdi
Journal:  Med Hypotheses       Date:  2011-03-12       Impact factor: 1.538

9.  Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors.

Authors:  U Leli; A Cataldo; T B Shea; R A Nixon; G Hauser
Journal:  J Neurochem       Date:  1992-04       Impact factor: 5.372

Review 10.  Sleeping giants: emerging roles for the fat cadherins in health and disease.

Authors:  Elham Sadeqzadeh; Charles E de Bock; Rick F Thorne
Journal:  Med Res Rev       Date:  2013-05-29       Impact factor: 12.944

View more
  13 in total

1.  Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Authors:  Zhiqiang Li; Pedram Razavi; Qing Li; Weiyi Toy; Bo Liu; Christina Ping; Wilson Hsieh; Francisco Sanchez-Vega; David N Brown; Arnaud F Da Cruz Paula; Luc Morris; Pier Selenica; Emily Eichenberger; Ronglai Shen; Nikolaus Schultz; Neal Rosen; Maurizio Scaltriti; Edi Brogi; Jose Baselga; Jorge S Reis-Filho; Sarat Chandarlapaty
Journal:  Cancer Cell       Date:  2018-12-10       Impact factor: 31.743

2.  T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.

Authors:  Charles E de Bock; Michelle Down; Kinsha Baidya; Bram Sweron; Andrew W Boyd; Mark Fiers; Gordon F Burns; Timothy J Molloy; Richard B Lock; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Jan Cools; Jeff Holst; Rick F Thorne
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

3.  Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.

Authors:  Alex Panaccione; Yi Zhang; Yanfang Mi; Yoshitsugu Mitani; Guo Yan; Manju L Prasad; W Hayes McDonald; Adel K El-Naggar; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Oral Oncol       Date:  2017-01-09       Impact factor: 5.337

4.  The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.

Authors:  Jacqueline E Mann; Aditi Kulkarni; Andrew C Birkeland; Judy Kafelghazal; Julia Eisenberg; Brittany M Jewell; Megan L Ludwig; Matthew E Spector; Hui Jiang; Thomas E Carey; J Chad Brenner
Journal:  Head Neck       Date:  2019-05-15       Impact factor: 3.821

5.  Transcriptional coactivator with PDZ-binding motif is required to sustain testicular function on aging.

Authors:  Mi Gyeong Jeong; Hyuna Song; Ji Hyun Shin; Hana Jeong; Hyo Kyeong Kim; Eun Sook Hwang
Journal:  Aging Cell       Date:  2017-06-14       Impact factor: 9.304

6.  Neuritin Inhibits Notch Signaling through Interacted with Neuralized to Promote the Neurite Growth.

Authors:  Pan Zhang; Xing Luo; Zheng Guo; Anying Xiong; Hongchang Dong; Qiao Zhang; Chunyan Liu; Jingling Zhu; Haiyan Wang; Na Yu; Jinli Zhang; Yu Hong; Lei Yang; Jin Huang
Journal:  Front Mol Neurosci       Date:  2017-06-08       Impact factor: 5.639

7.  Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.

Authors:  Daniel Martin; Maria S Degese; Lynn Vitale-Cross; Ramiro Iglesias-Bartolome; Juan Luis Callejas Valera; Zhiyong Wang; Xiaodong Feng; Huwate Yeerna; Vachan Vadmal; Toshiro Moroishi; Rick F Thorne; Moraima Zaida; Bradford Siegele; Sok C Cheong; Alfredo A Molinolo; Yardena Samuels; Pablo Tamayo; Kun Liang Guan; Scott M Lippman; J Guy Lyons; J Silvio Gutkind
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

8.  Identification of novel loci associated with infant cognitive ability.

Authors:  Ryan Sun; Zhaoxi Wang; Birgit Claus Henn; Li Su; Quan Lu; Xihong Lin; Robert O Wright; David C Bellinger; Molly Kile; Maitreyi Mazumdar; Martha Maria Tellez-Rojo; Lourdes Schnaas; David C Christiani
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

Review 9.  Mutations and Copy Number Abnormalities of Hippo Pathway Components in Human Cancers.

Authors:  Zhengjin He; Ruihan Li; Hai Jiang
Journal:  Front Cell Dev Biol       Date:  2021-06-03

Review 10.  WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.

Authors:  Shuai Chen; Han Wang; Yu-Fan Huang; Ming-Li Li; Jiang-Hong Cheng; Peng Hu; Chuan-Hui Lu; Ya Zhang; Na Liu; Chi-Meng Tzeng; Zhi-Ming Zhang
Journal:  Mol Cancer       Date:  2017-07-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.